Abbas Farhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abbas Farhan has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Farah Alam
Department of Medicine Manor Hospital, Walsall, UK
3 shared publications - Inshal Jawed
Dow Medical College, Karachi, Pakistan
3 shared publications - Abu Huraira Bin Gulzar
Department of Medicine, Services Institute of Medical Sciences, Lahore, Punjab, Pakistan
2 shared publications - Agha Muhammad Wali Mirza
Department of Internal Medicine, Jinnah Medical and Dental College, Karachi, Pakistan
2 shared publications Ali Syed
2 shared publications- Atika Sher
Liaquat National Hospital and Medical College Pakistan
2 shared publications
Latest Publications
- Open Access
- 25 June 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (8) , 5046-5055
Vitamin D and physical activity as co-modifiers of muscle health and function - a narrative exploration
Bone health requires different factors to grow. One of the main requirements is vitamin D. Much of the regulation of calcium levels also affects muscle strength and function, protein synthesis, and other cellular activities. Furthermore, the benefits of vitamin D on the muscular system are comparable to those of physical activity in terms of shaping the structural and functional changes in muscles. Our paper focuses on the synergistic effects of physical exercise and vitamin D on metabolism how they can impact muscle health, including the physiological rationale, outcomes of its deficiency, and measures for counteraction thereto. Here, we outline the effect of combined interventions for optimizing muscle strength.
- 25 June 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (8) , 5046-5055
Open AccessVitamin D and physical activity as co-modifiers of muscle health and function - a narrative exploration
Bone health requires different factors to grow. One of the main requirements is vitamin D. Much of the regulation of calcium levels also affects muscle strength and function, protein synthesis, and other cellular activities. Furthermore, the benefits of vitamin D on the muscular system are comparable to those of physical activity in terms of shaping the structural and functional changes in muscles. Our paper focuses on the synergistic effects of physical exercise and vitamin D on metabolism how they can impact muscle health, including the physiological rationale, outcomes of its deficiency, and measures for counteraction thereto. Here, we outline the effect of combined interventions for optimizing muscle strength.
- Open Access
- 13 June 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (8) , 5142-5152
Efficacy of botulinum toxin in the treatment of chronic anal fissure: a comprehensive systematic review
Acute anal fissure maintains a debilitating state that produces enduring wound damage on the anal mucosa while the internal anal sphincter demonstrates increased muscle tone. This study aims to conduct a comprehensive systematic review to evaluate the efficacy of botulinum toxin (BT) in the treatment of chronic anal fissure, synthesizing current evidence from clinical trials and observational studies to guide evidence-based practice. A review of systematic research investigates the performance and security along with extended outcomes linked to BT therapy for treating chronic anal fissure by analyzing 23 clinical studies. The healing response from BT injections reaches 60%–85% without producing headache side effects commonly experienced with topical glyceryl trinitrate (GTN) medications. Lateral internal sphincterotomy (LIS) produces excellent long-term healing results in 90%–95% of cases, although it leads to fecal incontinence risks at a 5%–15% rate. Expanding BT treatment usually necessitates additional injections or surgical intervention because of its high rate of recurrence over 1–3 years (30%–40%). Combining Botox treatment with GTN administration achieves healing rates between 70% and 80%, but studies provide inconsistent research data. The optimal dosage range for BT treatment is 20–30 units, while Botox performs equally well as Dysport in achieving these results. BT provides patients who do not want surgery the benefit of being a safe, minimally invasive procedure. At the same time, LIS offers a definitive solution for patients who cannot respond to other treatments. Research must establish standardized dose instructions while improving injection methods and developing extended strategies to stop relapses.
- 13 June 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (8) , 5142-5152
Open AccessEfficacy of botulinum toxin in the treatment of chronic anal fissure: a comprehensive systematic review
Acute anal fissure maintains a debilitating state that produces enduring wound damage on the anal mucosa while the internal anal sphincter demonstrates increased muscle tone. This study aims to conduct a comprehensive systematic review to evaluate the efficacy of botulinum toxin (BT) in the treatment of chronic anal fissure, synthesizing current evidence from clinical trials and observational studies to guide evidence-based practice. A review of systematic research investigates the performance and security along with extended outcomes linked to BT therapy for treating chronic anal fissure by analyzing 23 clinical studies. The healing response from BT injections reaches 60%–85% without producing headache side effects commonly experienced with topical glyceryl trinitrate (GTN) medications. Lateral internal sphincterotomy (LIS) produces excellent long-term healing results in 90%–95% of cases, although it leads to fecal incontinence risks at a 5%–15% rate. Expanding BT treatment usually necessitates additional injections or surgical intervention because of its high rate of recurrence over 1–3 years (30%–40%). Combining Botox treatment with GTN administration achieves healing rates between 70% and 80%, but studies provide inconsistent research data. The optimal dosage range for BT treatment is 20–30 units, while Botox performs equally well as Dysport in achieving these results. BT provides patients who do not want surgery the benefit of being a safe, minimally invasive procedure. At the same time, LIS offers a definitive solution for patients who cannot respond to other treatments. Research must establish standardized dose instructions while improving injection methods and developing extended strategies to stop relapses.
- 23 November 2024
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (1) , 104036
Evaluating the safety and efficacy of plasma therapy/plasmapheresis for systemic sclerosis – A comprehensive systematic review
- 23 November 2024
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (1) , 104036
Evaluating the safety and efficacy of plasma therapy/plasmapheresis for systemic sclerosis – A comprehensive systematic review
- Open Access
- 24 April 2024
- Published by Green Publication
- Vol. 31 (4) , 2221-2226
BREASTFEEDING GAPS AND MALNUTRITION: A STUDY ON CHILDREN UNDER TWO YEARS
Background: Malnutrition poses severe risks to children under two, causing stunted growth and weakened immunity. Exclusive breastfeeding for six months is advised to mitigate these risks, yet practices vary widely. Objective: This study examines the link between breastfeeding practices and malnutrition in Pakistani children under two. Methods: This observational prospective cohort study was conducted at Abbasi Shaheed Hospital, Karachi Pakistan in the duration from April, 2023 to September, 2023. It includes 348 children. The sample size was based on a 34.6% national malnutrition prevalence. Data were gathered through caregiver interviews, physical exams, and medical records. The primary outcome was malnutrition prevalence. Secondary outcomes included breastfeeding practices, socioeconomic status, and parental education. Analysis was performed using SPSS version 26.0, with chi-square tests and a significance level of p<0.05. Results: Malnutrition affected 34.6% of participants. Exclusive breastfeeding was linked to lower malnutrition rates (11% vs. 49%, p<0.05). Socioeconomic status and parental education were significant malnutrition predictors. Conclusion: Promoting exclusive breastfeeding and improving socioeconomic conditions are vital to reducing malnutrition in children under two. These insights can guide targeted interventions and public health policies to enhance child health outcomes.
- 24 April 2024
- Published by Green Publication
- Vol. 31 (4) , 2221-2226
Open AccessBREASTFEEDING GAPS AND MALNUTRITION: A STUDY ON CHILDREN UNDER TWO YEARS
Background: Malnutrition poses severe risks to children under two, causing stunted growth and weakened immunity. Exclusive breastfeeding for six months is advised to mitigate these risks, yet practices vary widely. Objective: This study examines the link between breastfeeding practices and malnutrition in Pakistani children under two. Methods: This observational prospective cohort study was conducted at Abbasi Shaheed Hospital, Karachi Pakistan in the duration from April, 2023 to September, 2023. It includes 348 children. The sample size was based on a 34.6% national malnutrition prevalence. Data were gathered through caregiver interviews, physical exams, and medical records. The primary outcome was malnutrition prevalence. Secondary outcomes included breastfeeding practices, socioeconomic status, and parental education. Analysis was performed using SPSS version 26.0, with chi-square tests and a significance level of p<0.05. Results: Malnutrition affected 34.6% of participants. Exclusive breastfeeding was linked to lower malnutrition rates (11% vs. 49%, p<0.05). Socioeconomic status and parental education were significant malnutrition predictors. Conclusion: Promoting exclusive breastfeeding and improving socioeconomic conditions are vital to reducing malnutrition in children under two. These insights can guide targeted interventions and public health policies to enhance child health outcomes.
- Open Access
- 27 January 2024
- Published by Green Publication
- Vol. 31 (6) , 3038-3042
COMPARATIVE STUDY OF PROBIOTICS AND PLACEBO IN THE PREVENTION OF NECROTIZING ENTEROCOLITIS IN PREMATURE INFANTS
Background: Necrotizing enterocolitis (NEC) severely impacts premature infants, leading to high morbidity and mortality rates. Despite medical advances, effective prevention remains elusive. Probiotics, which stabilize gut flora and boost immune responses, could be a viable preventive measure. Objective: This study evaluates the effectiveness of probiotics in reducing NEC incidence in a clinical setting, aiming to establish them as a standard preventive treatment. Methods: This observational prospective cohort study was conducted at Abbasi Shaheed Hospital, Karachi Pakistan in the duration from July, 2023 to December, 2023. it involves 102 preterm infants under 34 weeks gestational age. The study divided infants into two groups: those receiving daily probiotics (Lactobacillus and Bifidobacterium) and a control group without supplements. Primary outcomes included NEC incidence, mortality, and sepsis rates. Analysis was performed using SPSS, with Kaplan-Meier and Cox proportional hazards models. Results: Probiotics significantly reduced NEC incidence to 4% versus 16% in controls. Notable declines in mortality and sepsis were also observed. Probiotic recipients benefitted from better growth rates and shorter hospital stays. Conclusion: Probiotics markedly decrease NEC risks among preterm infants, advocating their integration into neonatal care. This study supports the broader implementation of probiotics as a straightforward, cost-effective strategy to avert a critical condition, reshaping care for at-risk neonates.
- 27 January 2024
- Published by Green Publication
- Vol. 31 (6) , 3038-3042
Open AccessCOMPARATIVE STUDY OF PROBIOTICS AND PLACEBO IN THE PREVENTION OF NECROTIZING ENTEROCOLITIS IN PREMATURE INFANTS
Background: Necrotizing enterocolitis (NEC) severely impacts premature infants, leading to high morbidity and mortality rates. Despite medical advances, effective prevention remains elusive. Probiotics, which stabilize gut flora and boost immune responses, could be a viable preventive measure. Objective: This study evaluates the effectiveness of probiotics in reducing NEC incidence in a clinical setting, aiming to establish them as a standard preventive treatment. Methods: This observational prospective cohort study was conducted at Abbasi Shaheed Hospital, Karachi Pakistan in the duration from July, 2023 to December, 2023. it involves 102 preterm infants under 34 weeks gestational age. The study divided infants into two groups: those receiving daily probiotics (Lactobacillus and Bifidobacterium) and a control group without supplements. Primary outcomes included NEC incidence, mortality, and sepsis rates. Analysis was performed using SPSS, with Kaplan-Meier and Cox proportional hazards models. Results: Probiotics significantly reduced NEC incidence to 4% versus 16% in controls. Notable declines in mortality and sepsis were also observed. Probiotic recipients benefitted from better growth rates and shorter hospital stays. Conclusion: Probiotics markedly decrease NEC risks among preterm infants, advocating their integration into neonatal care. This study supports the broader implementation of probiotics as a straightforward, cost-effective strategy to avert a critical condition, reshaping care for at-risk neonates.